New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus

被引:45
作者
Putterman, C [1 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Div Rheumatol, Irving & Ruth Claremon Res Lab, Bronx, NY 10461 USA
基金
美国国家卫生研究院;
关键词
systemic lupus erythematosus; anti-DNA antibodies; lupus nephritis; cross reactivity; cell penetration;
D O I
10.1016/S1568-9972(03)00082-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoantibodies against double stranded (ds) DNA are not only a helpful serological marker for diagnosis of systemic lupus erythematosus (SLE), but have also been shown to be crucial in the pathogenesis of lupus nephritis. However, the question of how anti-dsDNA antibodies contribute to renal damage is unresolved. Many authorities believe that indirect binding (mediated by nuclear antigens) or direct cross-reactivity of anti-dsDNA antibodies with kidney antigens are important determinants of anti-dsDNA nephritogenicity. An alternative hypothesis for the renal pathogenicity of anti-dsDNA antibodies was proposed more than 20 years ago, namely that certain autoantibodies could penetrate into living cells and thus induce damage. Work from several laboratories has recently provided firm support for this iconoclastic theory, which contradicted prevailing immunologic dogma that cell interiors are inaccessible to antibodies. Here, we review the evidence that anti-dsDNA antibodies may penetrate into living cells, and discuss which intracellular events may follow from binding of anti-dsDNA antibodies to the cell surface and subsequent intracellular penetration. Determining the mechanism by which anti-dsDNA antibodies induce renal injury is important for understanding a major disease manifestation of lupus, and may lead to the development of novel approaches to the treatment of lupus renal disease. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:97 / 101
页数:5
相关论文
共 41 条
[1]   LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus -: Results from a randomized, double-blind, placebo-controlled study [J].
Alarcón-Segovia, D ;
Tumlin, JA ;
Furie, RA ;
McKay, JD ;
Cardiel, MH ;
Strand, V ;
Bagin, RG ;
Linnik, MD ;
Hepburn, B .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :442-454
[2]   ANTIBODY TO NUCLEAR RIBONUCLEOPROTEIN PENETRATES LIVE HUMAN MONONUCLEAR-CELLS THROUGH FC RECEPTORS [J].
ALARCONSEGOVIA, D ;
RUIZARGUELLES, A ;
FISHBEIN, E .
NATURE, 1978, 271 (5640) :67-69
[3]   The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage [J].
AlarconSegovia, D ;
Llorente, L ;
RuizArguelles, A .
JOURNAL OF AUTOIMMUNITY, 1996, 9 (02) :295-300
[4]  
AlarconSegovia D, 1996, IMMUNOL TODAY, V17, P163
[5]   PREVENTION OF RELAPSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BOOTSMA, H ;
SPRONK, P ;
DERKSEN, R ;
DEBOER, G ;
WOLTERSDICKE, H ;
HERMANS, J ;
LIMBURG, P ;
GMELIGMEYLING, F ;
KATER, L ;
KALLENBERG, C .
LANCET, 1995, 345 (8965) :1595-1599
[6]   In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies [J].
Deng, SX ;
Hanson, E ;
Sanz, I .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (04) :415-423
[7]   Antigenic triggers and molecular targets for anti-double-stranded DNA antibodies [J].
Deocharan, B ;
Qing, X ;
Beger, E ;
Putterman, C .
LUPUS, 2002, 11 (12) :865-871
[8]   α-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies [J].
Deocharan, B ;
Qing, XP ;
Lichauco, J ;
Putterman, C .
JOURNAL OF IMMUNOLOGY, 2002, 168 (06) :3072-3078
[9]   HUMAN-IGG ANTI-DNA ANTIBODIES DEPOSIT IN KIDNEYS AND INDUCE PROTEINURIA IN SCID MICE [J].
EHRENSTEIN, MR ;
KATZ, DR ;
GRIFFITHS, MH ;
PAPADAKI, L ;
WINKLER, TH ;
KALDEN, JR ;
ISENBERG, DA .
KIDNEY INTERNATIONAL, 1995, 48 (03) :705-711
[10]   MOLECULAR AND STRUCTURAL-ANALYSIS OF NUCLEAR LOCALIZING ANTI-DNA LUPUS ANTIBODIES [J].
FOSTER, MH ;
KIEBEREMMONS, T ;
OHLIGER, M ;
MADAIO, MP .
IMMUNOLOGIC RESEARCH, 1994, 13 (2-3) :186-206